SCHEMBL31703579

SCHEMBL31703579

O=C(CN1CC[C@H](n2cncn2)C1)Nc1ccc(-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ HTT P42858 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ ADORA2B P29275 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ MGLL Q99685 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31703486 0.80 IDO1 (0.46) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL31703598 0.80 ALDH1A1 (0.47) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL31703966 0.80 IDO1 (0.46) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL31703383 0.80 MTNR1B (0.50) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL7736294 0.70 ALDH1A1 (0.78) MEN1KMT2AGAAHTTNPC1
SCHEMBL31703747 0.70 POLB (0.48) MEN1KMT2AHTTNPSR1
SCHEMBL5346039 0.69 HTT (0.60) MEN1KMT2AHTTRECQLNPSR1
SCHEMBL16900136 0.66 NPSR1 (0.67) MEN1KMT2AHTTRECQLNPSR1
SCHEMBL3224693 0.66 NPC1 (0.63) MEN1KMT2AHTTRECQLNPSR1
SCHEMBL2558691 0.66 NPSR1 (0.62) MEN1KMT2AHTTRECQLNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025217513-A1 ACTIVATION OF PLCG2 AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF ALZHEIMER'S DISEASE THE TRUSTEES OF INDIANA UNIVERSITY (US) 2025-10-16 — — WO claimed
WO-2025217513-A1 ACTIVATION OF PLCG2 AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF ALZHEIMER'S DISEASE THE TRUSTEES OF INDIANA UNIVERSITY (US) 2025-10-16 — — WO disclosed
Send feedback